{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:01:20Z","timestamp":1749096080716,"version":"3.41.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"French Investissements d'Avenir-Laboratory of Excellence","award":["ANR-11-LABX-0015-01"],"award-info":[{"award-number":["ANR-11-LABX-0015-01"]}]},{"name":"Italian Association against Epilepsy\u2013Italian Foundation for Research on Epilepsy","award":["AICE-FIRE RA86"],"award-info":[{"award-number":["AICE-FIRE RA86"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.neuropharm.2016.06.029","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T22:23:51Z","timestamp":1469053431000},"page":"223-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"PA","title":["Ranolazine vs phenytoin: greater effect of ranolazine on the transient Na+ current than on the persistent Na+ current in central neurons"],"prefix":"10.1016","volume":"110","author":[{"given":"Benedetta","family":"Terragni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Scalmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Franceschetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1070-7929","authenticated-orcid":false,"given":"Massimo","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.neuropharm.2016.06.029_bib1","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/epi.12657","article-title":"Antiepileptic activity of preferential inhibitors of persistent sodium current","volume":"55","author":"Anderson","year":"2014","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.neuropharm.2016.06.029_bib2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.neuropharm.2016.06.029_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-642-41588-3_7","article-title":"The role of late INa in development of cardiac arrhythmias","volume":"221","author":"Antzelevitch","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"issue":"Pt 11","key":"10.1016\/j.neuropharm.2016.06.029_bib4","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1113\/jphysiol.2011.224204","article-title":"Voltage-gated sodium channels at 60: structure, function and pathophysiology","volume":"590","author":"Catterall","year":"2012","journal-title":"J.\u00a0Physiol."},{"issue":"29","key":"10.1016\/j.neuropharm.2016.06.029_bib5","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1523\/JNEUROSCI.4453-07.2008","article-title":"Self-limited hyperexcitability: functional effect of a familial hemiplegic migraine mutation of the NaV1.1 (SCN1A) Na+ channel","volume":"28","author":"Cest\u00e8le","year":"2008","journal-title":"J.\u00a0Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2016.06.029_bib6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/epi.12123","article-title":"Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine","volume":"54","author":"Cest\u00e8le","year":"2013","journal-title":"Epilepsia"},{"issue":"43","key":"10.1016\/j.neuropharm.2016.06.029_bib7","doi-asserted-by":"crossref","first-page":"17546","DOI":"10.1073\/pnas.1309827110","article-title":"Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects","volume":"110","author":"Cest\u00e8le","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.neuropharm.2016.06.029_bib8","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/CIRCULATIONAHA.105.597500","article-title":"Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions","volume":"113","author":"Chaitman","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.029_bib9","doi-asserted-by":"crossref","first-page":"e55329","DOI":"10.1371\/journal.pone.0055329","article-title":"Phenytoin inhibits the persistent sodium current in neocortical neurons by modifying its inactivation properties","volume":"8","author":"Colombo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.06.029_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.ph.58.030196.002025","article-title":"Persistent sodium current in mammalian central neurons","volume":"58","author":"Crill","year":"1996","journal-title":"Annu. Rev. Physiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.029_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nm.2333","article-title":"The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease","volume":"17","author":"Dreier","year":"2011","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.06.029_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4161\/chan.5.2.14851","article-title":"Ranolazine block of human NaV1.4 sodium channels and paramyotonia congenita mutants","volume":"5","author":"El-Bizri","year":"2011","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.neuropharm.2016.06.029_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1744-8069-6-35","article-title":"Effects of ranolazine on wild-type and mutant hNaV1.7 channels and on DRG neuron excitability","volume":"6","author":"Estacion","year":"2010","journal-title":"Mol. Pain"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.06.029_bib14","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1152\/jn.1996.76.3.2125","article-title":"Kinetics of slow inactivation of persistent sodium current in layer V neurons of mouse neocortical slices","volume":"76","author":"Fleidervish","year":"1996","journal-title":"J.\u00a0Neurophysiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.029_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.bjp.0706709","article-title":"Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action","volume":"148","author":"Fredj","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.06.029_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s13311-014-0267-0","article-title":"Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental models","volume":"11","author":"Guerrini","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.neuropharm.2016.06.029_bib17","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.neuropharm.2012.01.021","article-title":"Block of Na+ currents and suppression of action potentials in embryonic rat dorsal root ganglion neurons by ranolazine","volume":"62","author":"Hirakawa","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.029_bib18","doi-asserted-by":"crossref","first-page":"H288","DOI":"10.1152\/ajpheart.00539.2010","article-title":"Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of NaV1.5 channels","volume":"300","author":"Huang","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.neuropharm.2016.06.029_bib19","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1476-5381.2010.00976.x","article-title":"Ranolazine selectively blocks persistent current evoked by epilepsy-associated NaV1.1 mutations","volume":"161","author":"Kahlig","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.029_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/mol.113.088492","article-title":"Ranolazine reduces neuronal excitability by interacting with inactivated states of brain sodium channels","volume":"85","author":"Kahlig","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.029_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2009.03.039","article-title":"Hyperexcitability, persistent Na+ conductances and neurodegeneration in amyotrophic lateral sclerosis","volume":"218","author":"Kiernan","year":"2009","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.029_bib22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0026-895X(25)09804-9","article-title":"Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons","volume":"46","author":"Kuo","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.029_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","volume":"52","author":"L\u00f6scher","year":"2011","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.029_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1085\/jgp.114.4.491","article-title":"Biophysical properties and slow voltage-dependent inactivation of a sustained sodium current in entorhinal cortex layer-II principal neurons: a whole-cell and single-channel study","volume":"114","author":"Magistretti","year":"1999","journal-title":"J.\u00a0Gen. Physiol."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2016.06.029_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1469-7793.1998.105bu.x","article-title":"Anemone toxin (ATX II) induced increase in persistent sodium current: effects on the firing properties of rat neocortical pyramidal neurones","volume":"507","author":"Mantegazza","year":"1998","journal-title":"J.\u00a0Physiol."},{"issue":"50","key":"10.1016\/j.neuropharm.2016.06.029_bib26","doi-asserted-by":"crossref","first-page":"18177","DOI":"10.1073\/pnas.0506818102","article-title":"Identification of an NaV1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures","volume":"102","author":"Mantegazza","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.neuropharm.2016.06.029_bib27","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1523\/JNEUROSCI.0104-05.2005","article-title":"Molecular determinants for modulation of persistent sodium current by G-protein \u00df\u03b3 subunits","volume":"25","author":"Mantegazza","year":"2005","journal-title":"J.\u00a0Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2016.06.029_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1113\/jphysiol.2005.093484","article-title":"\u00df-scorpion toxin effects suggest electrostatic interactions in domain II of voltage-dependent sodium channels","volume":"568","author":"Mantegazza","year":"2005","journal-title":"J.\u00a0Physiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.029_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(10)70059-4","article-title":"Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders","volume":"9","author":"Mantegazza","year":"2010","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.06.029_bib30","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0022-3565(25)22146-2","article-title":"Multiple actions of phenytoin on mouse spinal cord neurons in cell culture","volume":"227","author":"McLean","year":"1983","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.029_bib31","doi-asserted-by":"crossref","first-page":"H1615","DOI":"10.1152\/ajpheart.00243.2011","article-title":"Mechanisms of atrial-selective block of Na+ channels by ranolazine: II. Insights from a mathematical model","volume":"301","author":"Nesterenko","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"29","key":"10.1016\/j.neuropharm.2016.06.029_bib32","doi-asserted-by":"crossref","first-page":"9720","DOI":"10.1523\/JNEUROSCI.2395-13.2014","article-title":"Function of inhibitory micronetworks is spared by Na+ channel-acting anticonvulsant drugs","volume":"34","author":"Pothmann","year":"2014","journal-title":"J.\u00a0Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.06.029_bib33","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bph.12150","article-title":"Effects of the antianginal drug, ranolazine, on the brain sodium channel NaV1.2 and its modulation by extracellular protons","volume":"169","author":"Peters","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2016.06.029_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4161\/chan.2.6.7362","article-title":"Block of tetrodotoxin-sensitive, NaV1.7 and tetrodotoxin-resistant, NaV1.8, Na+ channels by ranolazine","volume":"2","author":"Rajamani","year":"2008","journal-title":"Channels (Austin)"},{"issue":"11","key":"10.1016\/j.neuropharm.2016.06.029_bib35","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.hrthm.2009.07.042","article-title":"Use-dependent block of cardiac late Na+ current by ranolazine","volume":"6","author":"Rajamani","year":"2009","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.neuropharm.2016.06.029_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.06.029_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0920-1211(94)90043-4","article-title":"Phenytoin concentrations in the human brain: an in\u00a0vivo microdialysis study","volume":"18","author":"Scheyer","year":"1994","journal-title":"Epilepsy Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2016.06.029_bib38","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/jps.2600660724","article-title":"Solubility and ionization characteristics of phenytoin","volume":"66","author":"Schwartz","year":"1977","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.neuropharm.2016.06.029_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fphar.2013.00078","article-title":"Proton-dependent inhibition of the cardiac sodium channel NaV1.5 by ranolazine","volume":"4","author":"Sokolov","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.06.029_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1535-7511.2007.00156.x","article-title":"Persistent sodium current and its role in epilepsy","volume":"7","author":"Stafstrom","year":"2007","journal-title":"Epilepsy Curr."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.06.029_bib41","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1124\/mol.107.041541","article-title":"State- and use-dependent block of muscle NaV1.4 and neuronal NaV1.7 voltage-gated Na+ channel isoforms by ranolazine","volume":"73","author":"Wang","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.06.029_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ncpneuro0735","article-title":"Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status","volume":"4","author":"Waxman","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"issue":"5","key":"10.1016\/j.neuropharm.2016.06.029_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0026-895X(25)12546-7","article-title":"Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells","volume":"27","author":"Willow","year":"1985","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2016.06.029_bib44","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn1754","article-title":"Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy","volume":"9","author":"Yu","year":"2006","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.06.029_bib45","doi-asserted-by":"crossref","first-page":"H1606","DOI":"10.1152\/ajpheart.00242.2011","article-title":"Mechanisms of atrial-selective block of Na+ channels by ranolazine: I. Experimental analysis of the use-dependent block","volume":"301","author":"Zygmunt","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816302829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816302829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T03:15:02Z","timestamp":1749006902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816302829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":45,"alternative-id":["S0028390816302829"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.06.029","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ranolazine vs phenytoin: greater effect of ranolazine on the transient Na+ current than on the persistent Na+ current in central neurons","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}